Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CNTG

Centogene (CNTG) Stock Price, News & Analysis

Centogene logo

About Centogene Stock (NASDAQ:CNTG)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.07
$0.35
52-Week Range
N/A
Volume
8.36 million shs
Average Volume
150,868 shs
Market Capitalization
$8.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CNTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Centogene and its competitors with MarketBeat's FREE daily newsletter.

CNTG Stock News Headlines

"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
CNTGF Centogene N.V.
Centogene N.V. (CNTG)
See More Headlines

CNTG Stock Analysis - Frequently Asked Questions

Centogene (NASDAQ:CNTG) issued its earnings results on Wednesday, November, 24th. The company reported ($1.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.59) by $0.49. The firm had revenue of $35.60 million for the quarter, compared to analysts' expectations of $31.91 million.

Centogene (CNTG) raised $60 million in an initial public offering (IPO) on Thursday, November 7th 2019. The company issued 4,000,000 shares at $14.00-$16.00 per share. SVB Leerink and Evercore ISI served as the underwriters for the IPO and Baird and BTIG were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Centogene investors own include Avino Silver & Gold Mines (ASM), Lincoln National (LNC), Advanced Micro Devices (AMD), Applied Genetic Technologies (AGTC), Catalyst Pharmaceuticals (CPRX), Fulcrum Therapeutics (FULC) and VBI Vaccines (VBIV).

Company Calendar

Last Earnings
11/24/2021
Today
7/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NASDAQ:CNTG
CIK
1757097
Fax
N/A
Employees
810
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.02
Quick Ratio
0.96

Sales & Book Value

Annual Sales
$48.54 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.01) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
27,080,000
Free Float
N/A
Market Cap
$8.80 million
Optionable
Not Optionable
Beta
-0.67
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:CNTG) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners